Literature DB >> 21078705

Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia.

Joel Swendsen1, Dror Ben-Zeev, Eric Granholm.   

Abstract

OBJECTIVE: Despite evidence demonstrating elevated comorbidity between schizophrenia and substance use disorders, the underlying mechanisms of association remain poorly understood. The brief time intervals that characterize interactions between substance use and psychotic symptoms in daily life are inaccessible to standard research protocols. The authors used electronic personal digital assistants (PDAs) to examine the temporal association of diverse forms of substance use with psychotic symptoms and psychological states in natural contexts.
METHOD: Of 199 community-dwelling individuals with schizophrenia or schizoaffective disorder who were contacted to participate in the study, 92% accepted and 73% completed the study. The 145 participants who completed the study provided reports of substance use, psychotic symptoms, mood, and event negativity multiple times per day over 7 consecutive days through PDAs.
RESULTS: Participants responded to 72% of the electronic interviews (N=2,737) across daily life contexts. Strong within-day prospective associations were observed in both directions between substance use and negative psychological states or psychotic symptoms, but considerable variation was observed by substance type. Consistent with the notion of self-medication, alcohol use was most likely to follow increases in anxious mood or psychotic symptoms. Cannabis and other illicit substances, demonstrating more complex patterns, were more likely to follow certain psychological states but were also associated with the later onset of psychotic symptoms.
CONCLUSIONS: The dynamic interplay of substance use and psychotic symptoms is in many cases consistent with both causal and self-medication mechanisms, and these patterns of association should be considered in the design of treatment and prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078705     DOI: 10.1176/appi.ajp.2010.10030463

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  41 in total

Review 1.  Mobile assessment guide for research in schizophrenia and severe mental disorders.

Authors:  David Kimhy; Inez Myin-Germeys; Jasper Palmier-Claus; Joel Swendsen
Journal:  Schizophr Bull       Date:  2012-01-27       Impact factor: 9.306

2.  Cannabis and alcohol use, affect and impulsivity in psychiatric out-patients' daily lives.

Authors:  Timothy J Trull; Andrea M Wycoff; Sean P Lane; Ryan W Carpenter; Whitney C Brown
Journal:  Addiction       Date:  2016-07-24       Impact factor: 6.526

3.  User profiles of an electronic mental health tool for ecological momentary assessment: MEmind.

Authors:  María Luisa Barrigón; Sofian Berrouiguet; Juan José Carballo; Covadonga Bonal-Giménez; Pablo Fernández-Navarro; Bernadette Pfang; David Delgado-Gómez; Philippe Courtet; Fuensanta Aroca; Jorge Lopez-Castroman; Antonio Artés-Rodríguez; Enrique Baca-García
Journal:  Int J Methods Psychiatr Res       Date:  2017-03-09       Impact factor: 4.035

4.  Technology-based interventions in health care.

Authors:  J M Kane
Journal:  Epidemiol Psychiatr Sci       Date:  2014-08-26       Impact factor: 6.892

Review 5.  The rational patient and beyond: implications for treatment adherence in people with psychiatric disabilities.

Authors:  Patrick W Corrigan; Nicolas Rüsch; Dror Ben-Zeev; Tamara Sher
Journal:  Rehabil Psychol       Date:  2014-01-20

6.  Gender and stress in predicting depressive symptoms following stroke.

Authors:  Carolyn M Mazure; Andrea H Weinberger; Brian Pittman; Igor Sibon; Joel Swendsen
Journal:  Cerebrovasc Dis       Date:  2014-11-13       Impact factor: 2.762

7.  Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.

Authors:  Susan Whitfield-Gabrieli; Adina S Fischer; Angela M Henricks; Jibran Y Khokhar; Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Schizophr Res       Date:  2017-08-18       Impact factor: 4.939

8.  Depressed mood in individuals with schizophrenia: A comparison of retrospective and real-time measures.

Authors:  Lisa H Blum; Julia Vakhrusheva; Alice Saperstein; Samira Khan; Rachel W Chang; Marie C Hansen; Vance Zemon; David Kimhy
Journal:  Psychiatry Res       Date:  2015-03-16       Impact factor: 3.222

9.  Predictors of Self-Stigma in Schizophrenia: New Insights Using Mobile Technologies.

Authors:  Dror Ben-Zeev; Rochelle Frounfelker; Scott B Morris; Patrick W Corrigan
Journal:  J Dual Diagn       Date:  2012-09-10

Review 10.  Affect and cannabis use in daily life: a review and recommendations for future research.

Authors:  Andrea M Wycoff; Jane Metrik; Timothy J Trull
Journal:  Drug Alcohol Depend       Date:  2018-08-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.